NCT07104812: Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)
- State
- Under way
- Phase
- Phase 2
- People
- 15 planned
- Started
- 14 Jan 2026
- Primary completion
- Jan 2027
- Arms
- Mild autonomous cortisol secretion (MACS)
- Results
- None posted
- 5 Aug 2025: Trial registered
- 14 Jan 2026: Trial started